- Home
- ABOS vs RGC Comparison
ABOS vs RGC Comparison
Compare ABOS & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABOS | RGC |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.9M | 3.1B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ABOS | RGC |
|---|---|---|
| Price | $2.57 | $5.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 331.3K | 166.8K |
| Earning Date | 05-12-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.21 | $4.51 |
| 52 Week High | $3.60 | $69.00 |
Technical Indicators
Market Signals| Indicator | ABOS | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 44.61 |
| Support Level | $2.76 | $4.71 |
| Resistance Level | $3.02 | $6.40 |
| Average True Range (ATR) | 0.18 | 0.55 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 30.00 | 18.62 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.